Variables | N(%) |
---|---|
Gender | |
Male (%) | 202 (88.6) |
Female (%) | 26 (11.4) |
Age (y) | median:64, min-max:41–82 |
Tumor location | |
Upper Tx (%) | 34 (14.9) |
Mid Tx (%) | 125 (54.8) |
Lower Tx (%) | 69 (30.3) |
Macroscopic tumor type | |
0-I | 70 (30.7) |
0-IIa | 45 (19.7) |
0-IIb | 3 (1.3) |
0-IIc | 103 (45.2) |
0-III | 7 (3.1) |
Tumor length(mm) | median:36, min-max:2–180 |
Differentiation | |
Well (%) | 58 (25.4) |
Moderate (%) | 86 (37.7) |
Poor (%) | 84 (36.8) |
Growth pattern | |
Expansive (%) | 82 (36.0) |
Infiltrative (%) | 146 (64.0) |
Lymphatic invasion | |
Absent (%) | 166 (72.8) |
Present (%) | 62 (27.2) |
Vascular invasion | |
Absent (%) | 189 (82.9) |
Present (%) | 39 (17.1) |
pT category | |
T1a (%) | 62 (27.2) |
M2 | 27 |
M3 | 35 |
T1b (%) | 166 (72.8) |
SM1 | 57 |
SM2 | 61 |
SM3 | 48 |
pN category | |
N0 (%) | 135 (59.2) |
N1 (%) | 69 (30.3) |
N2 (%) | 19 (8.3) |
N3 (%) | 5 (2.2) |
pM category | |
M0 (%) | 212 (93.0) |
M1 (lym) (%) | 16 (7.0) |
pStage | |
Stage I(%) | 133 (58.3) |
Stage II(%) | 64 (28.1) |
Stage III(%) | 15 (6.6) |
Stage IV (lym)(%) | 16 (7.0) |